Premium
Cytokine Release During Long‐Term Extracorporeal Circulation in an Experimental Model
Author(s) -
Adrian Katrin,
Mellgren Karin,
Skogby Maria,
Friberg Lars Göran,
Mellgren Gösta,
Wadenvik Hans
Publication year - 1998
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1046/j.1525-1594.1998.06121.x
Subject(s) - extracorporeal circulation , perfusion , extracorporeal membrane oxygenation , cytokine , medicine , extracorporeal , anesthesia , interleukin 1 receptor antagonist , receptor antagonist , tumor necrosis factor alpha , antagonist , immunology , pharmacology , receptor
The objective of this study was to determine the degree of leukocyte activation, as measured by cytokine release, in circulating blood during experimental extracorporeal circulation. Complete in vitro extracorporeal membrane oxygenation (ECMO) circuits were used, and 9 experiments were performed. Whole blood stored at 37°C was used as the control. Blood samples were withdrawn before the start of perfusion and at 24 h of perfusion. Statistically significant releases of interleukin (IL)‐1β, IL‐8, and IL‐1 receptor antagonist were observed in the perfusion circuits compared to both the control blood and baseline values. Also, increases in plasma tumor necrosis factor (TNF)α and IL‐6 were seen after 24 h of perfusion although these changes did not reach statistical significance. These results indicate that extracorporeal circulation induced leukocyte activation and cytokine release. These reactions might, as an additional trauma, deteriorate the situation in an already severely ill patient. A search for methods to counteract this untoward activation seems warranted.